» Articles » PMID: 36678267

Hypoxia-Driven Changes in a Human Intestinal Organoid Model and the Protective Effects of Hydrolyzed Whey

Abstract

Many whey proteins, peptides and protein-derived amino acids have been suggested to improve gut health through their anti-oxidant, anti-microbial, barrier-protective and immune-modulating effects. Interestingly, although the degree of hydrolysis influences peptide composition and, thereby, biological function, this important aspect is often overlooked. In the current study, we aimed to investigate the effects of whey protein fractions with different degrees of enzymatic hydrolysis on the intestinal epithelium in health and disease with a novel 2D human intestinal organoid (HIO) monolayer model. In addition, we aimed to assess the anti-microbial activity and immune effects of the whey protein fractions. Human intestinal organoids were cultured from adult small intestines, and a model enabling apical administration of nutritional components during hypoxia-induced intestinal inflammation and normoxia (control) in crypt-like and villus-like HIO was established. Subsequently, the potential beneficial effects of whey protein isolate (WPI) and two whey protein hydrolysates with a 27.7% degree of hydrolysis (DH28) and a 50.9% degree of hydrolysis (DH51) were assessed. In addition, possible immune modulatory effects on human peripheral immune cells and anti-microbial activity on four microbial strains of the whey protein fractions were investigated. Exposure to DH28 prevented paracellular barrier loss of crypt-like HIO following hypoxia-induced intestinal inflammation with a concomitant decrease in hypoxia inducible factor 1 alpha (HIF1α) mRNA expression. WPI increased Treg numbers and Treg expression of cluster of differentiation 25 (CD25) and CD69 and reduced CD4+ T cell proliferation, whereas no anti-microbial effects were observed. The observed biological effects were differentially mediated by diverse whey protein fractions, indicating that (degree of) hydrolysis influences their biological effects. Moreover, these new insights may provide opportunities to improve immune tolerance and promote intestinal health.

Citing Articles

Intestinal oxygen utilisation and cellular adaptation during intestinal ischaemia-reperfusion injury.

Archontakis-Barakakis P, Mavridis T, Chlorogiannis D, Barakakis G, Laou E, Sessler D Clin Transl Med. 2024; 15(1):e70136.

PMID: 39724463 PMC: 11670310. DOI: 10.1002/ctm2.70136.


A matter of differentiation: equine enteroids as a model for the in vivo intestinal epithelium.

Windhaber C, Heckl A, Csukovich G, Pratscher B, Burgener I, Biermann N Vet Res. 2024; 55(1):30.

PMID: 38493107 PMC: 10943904. DOI: 10.1186/s13567-024-01283-0.

References
1.
Urbauer E, Rath E, Haller D . Mitochondrial Metabolism in the Intestinal Stem Cell Niche-Sensing and Signaling in Health and Disease. Front Cell Dev Biol. 2021; 8:602814. PMC: 7813778. DOI: 10.3389/fcell.2020.602814. View

2.
Wan Y, Flavell R . TGF-beta and regulatory T cell in immunity and autoimmunity. J Clin Immunol. 2008; 28(6):647-59. PMC: 2837280. DOI: 10.1007/s10875-008-9251-y. View

3.
Kip A, Soons Z, Mohren R, Duivenvoorden A, Roth A, Cillero-Pastor B . Proteomics analysis of human intestinal organoids during hypoxia and reoxygenation as a model to study ischemia-reperfusion injury. Cell Death Dis. 2021; 12(1):95. PMC: 7813872. DOI: 10.1038/s41419-020-03379-9. View

4.
Poolman J, Anderson A . Escherichia coli and Staphylococcus aureus: leading bacterial pathogens of healthcare associated infections and bacteremia in older-age populations. Expert Rev Vaccines. 2018; 17(7):607-618. DOI: 10.1080/14760584.2018.1488590. View

5.
Chang J . Pathophysiology of Inflammatory Bowel Diseases. N Engl J Med. 2020; 383(27):2652-2664. DOI: 10.1056/NEJMra2002697. View